Huang James 13D/13G Filings for CASI Pharmaceuticals, Inc. (CASI)

Huang James 13D and 13G filings for CASI Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-29
4:05 pm
Purchase
2024-09-3013GCASI Pharmaceuticals, Inc.
CASI
Huang James1,435,000
9.200%
305,000increase
(+26.99%)
Filing
2024-06-11
4:10 pm
Sale
2024-06-1013GCASI Pharmaceuticals, Inc.
CASI
Huang James1,130,000
8.400%
-1,565,000decrease
(-58.07%)
Filing
2024-01-26
08:31 am
Purchase
2024-01-2513GCASI Pharmaceuticals, Inc.
CASI
Huang James2,695,000
19.990%
268,000increase
(+11.04%)
Filing
2023-11-09
4:13 pm
Purchase
2023-11-0913GCASI Pharmaceuticals, Inc.
CASI
Huang James2,427,000
18.000%
677,000increase
(+38.69%)
Filing
2023-06-22
9:15 pm
Purchase
2023-06-1613GCASI Pharmaceuticals, Inc.
CASI
Huang James1,750,000
13.000%
520,000increase
(+42.28%)
Filing
2023-04-10
11:22 am
Purchase
2023-03-2913GCASI Pharmaceuticals, Inc.
CASI
Huang James1,230,000
9.200%
1,230,000increase
(New Position)
Filing